PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,934,000 | -26.5% | 153,238 | -3.8% | 0.18% | -11.1% |
| Q1 2022 | $12,159,000 | +2.6% | 159,316 | -19.1% | 0.20% | +10.6% |
| Q4 2021 | $11,846,000 | +5.3% | 196,880 | -2.0% | 0.18% | +2.9% |
| Q3 2021 | $11,255,000 | -10.9% | 200,988 | -3.4% | 0.18% | -8.4% |
| Q2 2021 | $12,631,000 | -16.5% | 208,154 | -3.6% | 0.19% | -21.7% |
| Q1 2021 | $15,128,000 | +26.7% | 215,842 | +8.1% | 0.24% | +13.0% |
| Q4 2020 | $11,943,000 | -4.7% | 199,584 | -4.2% | 0.22% | -18.5% |
| Q3 2020 | $12,526,000 | +35.1% | 208,344 | +17.9% | 0.26% | +17.8% |
| Q2 2020 | $9,274,000 | +68.6% | 176,753 | +7.7% | 0.22% | +39.8% |
| Q1 2020 | $5,501,000 | -26.1% | 164,048 | -0.1% | 0.16% | +0.6% |
| Q4 2019 | $7,441,000 | +62.3% | 164,263 | +34.6% | 0.16% | +48.1% |
| Q3 2017 | $4,584,000 | -14.0% | 122,083 | +9.2% | 0.11% | -17.6% |
| Q2 2017 | $5,331,000 | +3.0% | 111,756 | -1.5% | 0.13% | -1.5% |
| Q1 2017 | $5,174,000 | +147.8% | 113,461 | +75.6% | 0.13% | +141.8% |
| Q4 2016 | $2,088,000 | -6.5% | 64,631 | -1.0% | 0.06% | -9.8% |
| Q3 2016 | $2,234,000 | – | 65,287 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |